Immediate Impact
3 from Science/Nature 76 standout
Citing Papers
N6-methyladenosine regulated FGFR4 attenuates ferroptotic cell death in recalcitrant HER2-positive breast cancer
2022 Standout
Breast cancer
2021 Standout
Works of F. Erdkamp being referenced
Abstract S1-03: First results from the multicenter phase III DATA study comparing 3 versus 6 years of anastrozole after 2-3 years of tamoxifen in postmenopausal women with hormone receptor-positive early breast cancer
2017
Randomized study comparing efficacy/toxicity of monotherapy trastuzumab followed by monotherapy docetaxel at progression, and combination trastuzumab/docetaxel as first-line chemotherapy in HER2-neu positive, metastatic breast cancer (MBC) (HERTAX study)
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| F. Erdkamp | 143 | 82 | 27 | 37 | 14 | 181 | |
| David Papadimos | 86 | 69 | 38 | 30 | 11 | 203 | |
| Uriel Bohn | 139 | 83 | 15 | 23 | 15 | 246 | |
| K.H. Link | 162 | 65 | 69 | 18 | 15 | 288 | |
| Zorka Inić | 88 | 28 | 18 | 24 | 16 | 176 | |
| Johan M. van Rooijen | 138 | 57 | 37 | 36 | 16 | 214 | |
| Jean-François Fléjou | 98 | 68 | 83 | 39 | 14 | 261 | |
| K. Lorizzo | 155 | 85 | 24 | 27 | 20 | 225 | |
| Marco Schupp | 87 | 42 | 21 | 26 | 17 | 161 | |
| Arteid Memaj | 198 | 69 | 56 | 102 | 17 | 267 | |
| M. Frisinghelli | 80 | 86 | 50 | 18 | 21 | 166 |
All Works
Loading papers...